PATENT CLAIM ANALYSIS

Application Number: 15873998
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "04400A"]

Abstract:
microRNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone-associated medical conditions are provided.

Claim (Index 12):
The nucleic acid construct of  claim 11 , wherein said cis acting regulatory element is active in a neuroglia cell or a cardiac cell.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 86.0
- Lexical Diversity: 1.22727
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14236928', '14856697', '15111539', '14421950', '15110108']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8159810974864669
- 35 USC 102 Novelty (BERT): 0.6338804623903828
- Combined Prediction Score: 0.7977710339768584
- Mean Citation Score: 526.43079
- Max Citation Score: 723.60614
- Similarity Product: 508.697408881011

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test